Centre Hospitalier Universite de Sherbrooke (CHUS)

Sherbrooke, Quebec J1H 5N4

0 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, Familial Chylomicronemia Syndrome, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early